Latest by Myles Helfand

What the Heck Is the HIV "Treatment Cascade" -- And Why Does It Matter?

If you haven't heard the phrase "treatment cascade" yet, you will: The concept is transforming the way we look at HIV care in the U.S. It also provides a really cool reminder of how powerful it can be to portray data in a more visually appealing way,...

By Myles Helfand

Aging With HIV: A New Journey

Today, living out a full, long life with HIV is not only common; it's expected, provided you're able to access modern HIV treatment and quality health care. And yet, over the past few years, we have only begun to truly grasp exactly what it means to ...

By Myles Helfand

"Premature Aging" and HIV: Dispelling Myths and Calculating Risk

Here's the bottom line on "accelerated aging" among people with HIV: It's probably not as bad as you think. New research is rewriting much of we thought we knew about aging and HIV.

By Myles Helfand

Eliminating HIV/AIDS: How We'll Get to Zero

So far, HIV has eluded every one of our efforts to wipe it off the face of the earth. But we do have a growing number of ideas and methods that can each do their part to control HIV. Here we introduce seven pieces of the puzzle: None of them can stop H…

By Myles Helfand and Kellee Terrell

Six Major HIV/AIDS Stories You May Have Missed

If you feel as if you haven’t heard a whole lot about HIV within the U.S. over the past few years … you’re right. Although 50,000 Americans become HIV positive each year and well over a million are living with the virus, it gets little attention from th...

By Myles Helfand

You and Your Meds: The Dance of a Lifetime

As the saying goes: It takes two to tango. If you're on HIV treatment, those antiretrovirals you take every day are your lifelong dance partner. With good preparation and coordination, you and your meds will dance together beautifully -- a partnershi...

By Myles Helfand

Talking to Your Health Care Provider About HIV Treatment Adherence Issues

When it comes to good adherence, one of the most important pieces of the puzzle is having a strong relationship with your health care team. Here we share some important tips on how to make sure you and your doctor, nurse or other health care professi...

By Myles Helfand and Benjamin Young, M.D., Ph.D.

10 Questions to Ask Yourself Before You Begin HIV Treatment

An HIV diagnosis comes with its own new set of questions to ask yourself and decisions to make. Among the biggest is: When should you start treatment? It’s a Russian nesting doll of a decision, with many other questions tucked inside. HIV/AIDS advocate…

By Heidi M. Nass and Myles Helfand

FDA Approves Complera (Edurant + Truvada), a Second "All-in-One" Option for First-Line HIV Treatment

When it comes to single-pill HIV treatment regimens in the U.S., Atripla is no longer the only game in town. The U.S. Food and Drug Administration has just approved Complera, a once-daily tablet that contains Truvada (tenofovir/FTC) and the NNRTI Edu...

By Myles Helfand

Revised U.S. HIV Treatment Guidelines Include Minor Changes, Reassurance on Viral Load "Blips": A Blog Entry by Myles Helfand

Newly updated official U.S. HIV treatment guidelines were released this morning -- the first revision since December 2009. The guidelines include no major changes to the questions of "when to start" or "what to start with." However, they do include ...

By Myles Helfand